| EPB0151 | Hepatitis delta and liver disease among people living with hepatitis B in Senegal | E-poster | Co-infections (including opportunistic infections) |
| EPB0152 | Hepatocellular carcinoma surveillance among people living with hepatitis B in Senegal: 1-year results of a prospective cohort study | E-poster | Co-infections (including opportunistic infections) |
| EPE0997 | Here we go NGO - role of the non-governmental sector in the HIV response and implications for transdisciplinary implementation science: a scoping review | E-poster | Innovations in data collection, monitoring and evaluation |
| TUPED01 | HÉROS: A community- and person-centered design of healthcare service for GBMSM engaging in chemsex in Taiwan | Poster exhibition | Key populations and other vulnerable populations: Behavioural, social and cultural issues and contexts |
| EPC0496 | Heterogeneity among people re-engaging in antiretroviral therapy highlights the need for a differentiated approach: results from a cohort study in Johannesburg, South Africa | E-poster | Cascades of HIV care and treatment |
| EPA0098 | Heterogeneity in neutralizing antibody responses following COVID-19 vaccination in Japanese people living with HIV | E-poster | SARS-CoV-2 virology, pathogenesis, and host immune responses, vaccines and immunotherapies |
| EPB0258 | High acceptability and preference for pediatric dolutegravir 10mg among children living with HIV in Nigeria at 1- and 6-month follow up, an observational study | E-poster | Antiretroviral therapies and clinical issues in infants, children and adolescents |
| EPC0480 | High dynamic range serologic recency assays can support VL monitoring during ART | E-poster | Cascades of HIV care and treatment |
| EPE0765 | High HIV prevalence among sexual partners with risk of intimate partner violence: results from index testing implementation in Zambia | E-poster | Implementation science and scale up of HIV testing |
| OALBC0604 | High in-hospital mortality in SARS-CoV-2 infected patients living with HIV during pre-Delta, Delta and Omicron variant waves: finding from the WHO Global Clinical Platform for COVID-19 | Oral abstract session with live Q&A | Epidemiology of COVID-19 |